Creative Planning’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
39,229
-7,657
-16% -$32.5K ﹤0.01% 3859
2025
Q4
$169K Buy
46,886
+10,508
+29% +$45.8K ﹤0.01% 3600
2025
Q3
$137K Sell
36,378
-4,786
-12% -$18.5K ﹤0.01% 3605
2025
Q2
$159K Buy
41,164
+9,558
+30% +$51.7K ﹤0.01% 3309
2025
Q1
$158K Sell
31,606
-5,392
-15% -$34.2K ﹤0.01% 3142
2024
Q4
$267K Buy
36,998
+18,587
+101% +$142K ﹤0.01% 2760
2024
Q3
$96.4K Buy
18,411
+6,132
+50% +$41.5K ﹤0.01% 3021
2024
Q2
$81.7K Buy
12,279
+500
+4% +$3.69K ﹤0.01% 2878
2024
Q1
$120K Sell
11,779
-300
-2% -$3.05K ﹤0.01% 2673
2023
Q4
$136K Buy
+12,079
New +$50.4K ﹤0.01% 2527
2020
Q4
Sell
-25,919
Closed -$342K 2343
2020
Q3
$342K Buy
+25,919
New +$518K ﹤0.01% 1338
2017
Q3
Sell
-30
Closed -$3K 1946
2017
Q2
$3K Hold
30
﹤0.01% 4157
2017
Q1
$7K Hold
30
﹤0.01% 3775
2016
Q4
$29K Hold
30
﹤0.01% 2814
2016
Q3
$26K Hold
30
﹤0.01% 2858
2016
Q2
$22K Hold
30
﹤0.01% 2715
2016
Q1
$17K Sell
30
-42
-58% -$21.5K ﹤0.01% 2856
2015
Q4
$41K Buy
+72
New +$35.9K ﹤0.01% 2270
2014
Q4
Sell
-3
Closed -$2K 4135
2014
Q3
$2K Sell
3
-4
-57% -$2.09K ﹤0.01% 3626
2014
Q2
$3K Hold
7
﹤0.01% 3382
2014
Q1
$4K Buy
+7
New +$4.09K ﹤0.01% 3154

Other funds holding ALT

Creative Planning's ALT Position: Q1 2026 in Review

Creative Planning reduced its Altimmune (ALT) stake by 16% in Q1 2026, selling an estimated $32.5K and leaving 39,229 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Creative Planning first reported a position in ALT in Q1 2014 and has held it in 21 quarters since. The position peaked at $342K in Q3 2020. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Creative Planning held 39,229 shares of Altimmune worth $121K as of Q1 2026.
  • Creative Planning sold 7,657 Altimmune shares in Q1 2026, an estimated $32.5K.
  • Altimmune made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3859 holding.
  • Creative Planning first reported a position in Altimmune in Q1 2014 and has held it in 21 quarters since.
  • Creative Planning's Altimmune position peaked at $342K in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.